Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-002638

T2 Biosystems, Inc. · TTOO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas J. Lowery
Officer — Chief Scientific Officer
Period of report
Nov 30, 2017
Accepted (ET)
Feb 5, 2019 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 30, 2017M15,000—A58,226D
Common StockF1Nov 30, 2018M15,000—A73,226D
Common StockF2Jan 31, 2019S2,166$3.35D71,060D
Common StockF3Feb 1, 2019S4,185$3.47D66,875D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F4—Nov 30, 2017M15,000D——Common Stock15,0000D
Restricted Stock UnitsF1,F4—Nov 30, 2018M15,000D——Common Stock15,0000D

Explanation of responses